Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
Sales of cough, cold and allergy (hay fever) remedies in Japan have continued to recover in 2023. This is largely due to increased opportunities for consumers to go out and a shift away from the practice of wearing face masks on a daily basis. With…
Although the pandemic is considered over, this is not expected to immediately reduce sales of OTC cough and cold medicines in Indonesia in 2023, with both retail volume and current value growth set to continue across most categories. However, the…
In 2023, cough, cold, and allergy (hay fever) remedies in India is set to experience moderate single-digit current value growth, driven predominantly by the demand for decongestants. Decongestants is expected to demonstrate above-average growth due…
The removal of mask-wearing and social distancing measures in March 2023 led to rising demand for cough, cold and allergy remedies as respiratory infections increased. Since February 2020, local seasonal influenza in Hong Kong has remained at a low…
Even though cough, cold and allergy (hay fever) remedies recorded over 40% current value growth in 2022, it is anticipated that the category will continue to achieve high single-digit growth in 2023. Starting from late 2022, the end of the zero-COVID…